SPI
18.679,72
PKT
+208,96
PKT
+1,13
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 06.11.12 | Burckhardt Compression hold | Vontobel Research | |
| 06.11.12 | Partners Group buy | Sarasin Research | |
| 06.11.12 | dormakaba hold | Vontobel Research | |
| 06.11.12 | Adecco SA buy | Sarasin Research | |
| 06.11.12 | Adecco SA buy | Vontobel Research | |
| 05.11.12 | Swiss Re sell | Goldman Sachs Group Inc. | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 05.11.12 | Roche neutral | Citigroup Corp. | |
| 05.11.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 05.11.12 | Partners Group hold | Vontobel Research | |
| 05.11.12 | Partners Group neutral | Sarasin Research | |
| 05.11.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 05.11.12 | Avolta (ex Dufry) neutral | Sarasin Research | |
| 05.11.12 | Calida hold | Vontobel Research | |
| 05.11.12 | UBS buy | Citigroup Corp. | |
| 06.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 02.11.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 02.11.12 | UBS buy | Société Générale Group S.A. (SG) | |
| 02.11.12 | Ypsomed hold | Vontobel Research | |
| 02.11.12 | Geberit hold | Vontobel Research | |
| 02.11.12 | Burckhardt Compression hold | Vontobel Research | |
| 01.11.12 | UBS buy | Nomura | |
| 01.11.12 | Avolta (ex Dufry) outperform | Exane-BNP Paribas SA | |
| 01.11.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 01.11.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 01.11.12 | Lonza hold | Vontobel Research | |
| 01.11.12 | DKSH hold | Vontobel Research | |
| 01.11.12 | Schindler hold | Vontobel Research | |
| 01.11.12 | Ypsomed hold | Vontobel Research | |
| 01.11.12 | Rieter buy | Vontobel Research | |
| 01.11.12 | Sika hold | Vontobel Research | |
| 01.11.12 | Clariant buy | Vontobel Research | |
| 01.11.12 | Swisscom hold | Vontobel Research | |
| 01.11.12 | UBS halten | Independent Research GmbH | |
| 01.11.12 | UBS buy | Sarasin Research | |
| 01.11.12 | Swisscom neutral | Sarasin Research | |
| 31.10.12 | UBS outperform | Exane-BNP Paribas SA | |
| 31.10.12 | Straumann neutral | Nomura |